CenterBook Partners’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-153,849
Closed -$2.22M 763
2026
Q1
$2.22M Buy
+153,849
New +$2.21M 0.12% 222

Other funds holding FOLD

CenterBook Partners's FOLD Position: Q2 2026 in Review

CenterBook Partners sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 153,849 shares — an estimated $2.22M sold.

CenterBook Partners first reported a position in FOLD in Q1 2026 and held it in 1 quarter. The position peaked at $2.22M in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • CenterBook Partners reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • CenterBook Partners sold 153,849 Amicus Therapeutics shares in Q2 2026, an estimated $2.22M.
  • CenterBook Partners first reported a position in Amicus Therapeutics in Q1 2026 and held it in 1 quarter.
  • CenterBook Partners's Amicus Therapeutics position peaked at $2.22M in Q1 2026.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on CenterBook Partners's 13F filing for Q2 2026, filed 11 Aug 2026.